UK small-cap RNS · 27 May 2026
Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.
| Date | Company | Mcap | Holder | Stake | Crossed | |
|---|---|---|---|---|---|---|
| 27 May | Future FUTR | £252m | JPMorgan Chase & Co. | 6.1% → 6.37% | ||
| 27 May | Renalytix RENX | £40m | UBS Group AG - Investment Bank & Global Wealth Management | 0% → 7.58% | 5% | |
| 27 May | Optima Health OPT | £265m | UBS Group AG - Investment Bank & Global Wealth Management | 0% → 5.33% | 5% | |
| 27 May | Nichols NICL | £397m | Octopus Investments Limited | 7.99% → 8.09% | ||
| 27 May | Verici DX VRCI | £8.9m | UBS Group AG - Investment Bank & Global Wealth Management | 0% → 7.82% | 5% | |
| 27 May | Palace Capital PCA | £30m | Peter Gyllenhammar AB | 7.03% → 8.06% | ||
| 27 May | Premier Miton Group PMI | £48m | Premier Miton Group plc | 15.67% | 15% | |
| 27 May | Kier Group KIE | £1,303m | UBS Group AG-Investment Bank & Global Wealth Management | 0% → 6.53% | 5% |
Notifications of major holdings (TR-1): a holder crossing 3%, 5%, 10% … of the voting rights. Transfers inside a group are left out.